LYELL IMMUNOPHARMA ($LYEL) posted quarterly earnings results on Tuesday, August 12th. The company reported earnings of -$2.89 per share, beating estimates of -$3.65 by $0.76. The company also reported revenue of $8,000, beating estimates of $0 by $8,000.
You can see Quiver Quantitative's $LYEL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LYELL IMMUNOPHARMA Insider Trading Activity
LYELL IMMUNOPHARMA insiders have traded $LYEL stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $LYEL stock by insiders over the last 6 months:
- SUMANT RAMACHANDRA purchased 200,000 shares for an estimated $115,219
- CHARLES W. NEWTON (Chief Financial Officer) purchased 200,000 shares for an estimated $111,620
- LYNN SEELY (President and CEO) purchased 175,000 shares for an estimated $106,190
- RICHARD KLAUSNER purchased 158,000 shares for an estimated $94,942
- OTIS W BRAWLEY purchased 35,640 shares for an estimated $19,958
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LYELL IMMUNOPHARMA Hedge Fund Activity
We have seen 21 institutional investors add shares of LYELL IMMUNOPHARMA stock to their portfolio, and 63 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ORBIMED ADVISORS LLC removed 3,103,623 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $1,669,749
- ALMITAS CAPITAL LLC added 1,432,086 shares (+136.3%) to their portfolio in Q1 2025, for an estimated $770,462
- MILLENNIUM MANAGEMENT LLC removed 914,550 shares (-95.5%) from their portfolio in Q1 2025, for an estimated $492,027
- D. E. SHAW & CO., INC. removed 889,087 shares (-92.0%) from their portfolio in Q1 2025, for an estimated $478,328
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 826,322 shares (-59.6%) from their portfolio in Q1 2025, for an estimated $444,561
- FORESITE CAPITAL MANAGEMENT IV, LLC removed 800,400 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $7,075,536
- UBS GROUP AG removed 753,886 shares (-87.2%) from their portfolio in Q1 2025, for an estimated $405,590
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
